摘要
目的研究米非司酮配伍米索前列醇终止剖宫产后早期妊娠的安全性与临床效果。方法选择剖宫产后早期妊娠102例,并将同期自然流产后早孕78例和无分娩史早孕妇女129例作为对照。常规使用米非司酮配伍米索前列醇药物流产方法。记录给药时间、孕囊排出时间、阴道出血量、药物不良反应、术后阴道出血天数、宫腔残留情况及月经恢复情况。结果米非司酮配伍米索前列醇终止剖宫产后早期妊娠、剖宫产后早孕组与自然分娩后早孕组及无分娩史早孕组的孕囊排出时间、完全流产率及月经恢复情况无明显差异,药物流产后阴道流血天数及阴道出血量差别也无显著性意义。结论米非司酮配伍米索前列醇终止剖宫产后早期妊娠安全性及有效性令人满意。
OBJECTIVE To observe the effctiveness and clinic accept ability of medical abortion of early pregnancy induced by miferprestone accompanied with misoprostol.METHODS 102 women,who had early pregnancies after cesarean section, were compared with 78 women with early pregnancy after natural delivery and 129 women having no birth. Miferprestone and misoprostol were given in the routine way. Several items were recorded: drugs acting time, gestation sac passing out time, vaginal bleeding, side effects of the drugs, remainder in uterus or not and menstruation recovery days. RESULTS Comparison of several key items such as gestation sac passing out time, complete abortion rate, vaginal bleeding and menstruation recovery days, no obvious differences were observed in these three groups.CONCLUSION It is secure to process medical abortion of early pregnancy induced by miferprestone accompanied with misoprostol.
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2005年第3期260-262,共3页
Chinese Journal of Modern Applied Pharmacy
关键词
米非司酮
剖宫产
早期妊娠
miferprestone
early pregnancy
cesarean section
